These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 36988452

  • 1. Non-fatal intoxications involving the novel benzodiazepine clonazolam: case series from the Emerging Drugs Network of Australia - Victoria project.
    Syrjanen R, Greene SL, Castle JW, Di Rago M, Hodgson SE, Abouchedid R, Graudins A, Schumann JL.
    Clin Toxicol (Phila); 2023 Apr; 61(4):290-293. PubMed ID: 36988452
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022.
    Syrjanen R, Greene SL, Weber C, Smith JL, Hodgson SE, Abouchedid R, Gerostamoulos D, Maplesden J, Knott J, Hollerer H, Rotella JA, Graudins A, Schumann JL, EDNAV project research group.
    Int J Drug Policy; 2023 Dec; 122():104245. PubMed ID: 37944339
    [Abstract] [Full Text] [Related]

  • 4. From signal to alert: A cluster of exposures to counterfeit alprazolam tablets containing five novel benzodiazepines.
    Syrjanen R, Schumann J, Hodgson SE, Abouchedid R, Rotella JA, Graudins A, Greene SL.
    Emerg Med Australas; 2023 Feb; 35(1):165-167. PubMed ID: 36271800
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A risk-based approach to community illicit drug toxicosurveillance: operationalisation of the Emerging Drugs Network of Australia - Victoria (EDNAV) project.
    Syrjanen R, Schumann JL, Lyons T, McKinnon G, Hodgson SE, Abouchedid R, Gerostamoulos D, Koutsogiannis Z, Fitzgerald J, Greene SL, EDNAV project research group.
    Int J Drug Policy; 2023 Dec; 122():104251. PubMed ID: 37952318
    [Abstract] [Full Text] [Related]

  • 10. Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposes.
    Meyer MR, Bergstrand MP, Helander A, Beck O.
    Anal Bioanal Chem; 2016 May; 408(13):3571-91. PubMed ID: 27071765
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project.
    Beck O, Franzen L, Bäckberg M, Signell P, Helander A.
    Clin Toxicol (Phila); 2015 Nov; 53(9):865-73. PubMed ID: 26462932
    [Abstract] [Full Text] [Related]

  • 16. Blood concentrations of new designer benzodiazepines in forensic cases.
    Høiseth G, Tuv SS, Karinen R.
    Forensic Sci Int; 2016 Nov; 268():35-38. PubMed ID: 27685473
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Metabolic profiling of clonazolam in human liver microsomes and zebrafish models using liquid chromatography quadrupole Orbitrap mass spectrometry.
    Kong R, Zhao J, Zhai W, Chen Z, Yang S, Chen M, Lin J, Wu L, Liu W, Xiang P.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb 01; 1216():123583. PubMed ID: 36621072
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.